Disruption of Early Tumor Necrosis Factor Alpha Signaling Prevents Classical Activation of Dendritic Cells in Lung-Associated Lymph Nodes and Development of Protective Immunity against Cryptococcal Infection

ABSTRACT Anti-tumor necrosis factor alpha (anti-TNF-α) therapies have been increasingly used to treat inflammatory diseases and are associated with increased risk of invasive fungal infections, including Cryptococcus neoformans infection. Using a mouse model of cryptococcal infection, we investigate...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jintao Xu, Alison J. Eastman, Adam Flaczyk, Lori M. Neal, Guolei Zhao, Jacob Carolan, Antoni N. Malachowski, Valerie R. Stolberg, Mohammed Yosri, Stephen W. Chensue, Jeffrey L. Curtis, John J. Osterholzer, Michal A. Olszewski
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2016
Materias:
Acceso en línea:https://doaj.org/article/bc50d61b42f745fba1b55ad5c2d86803
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bc50d61b42f745fba1b55ad5c2d86803
record_format dspace
spelling oai:doaj.org-article:bc50d61b42f745fba1b55ad5c2d868032021-11-15T15:50:18ZDisruption of Early Tumor Necrosis Factor Alpha Signaling Prevents Classical Activation of Dendritic Cells in Lung-Associated Lymph Nodes and Development of Protective Immunity against Cryptococcal Infection10.1128/mBio.00510-162150-7511https://doaj.org/article/bc50d61b42f745fba1b55ad5c2d868032016-09-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.00510-16https://doaj.org/toc/2150-7511ABSTRACT Anti-tumor necrosis factor alpha (anti-TNF-α) therapies have been increasingly used to treat inflammatory diseases and are associated with increased risk of invasive fungal infections, including Cryptococcus neoformans infection. Using a mouse model of cryptococcal infection, we investigated the mechanism by which disruption of early TNF-α signaling results in the development of nonprotective immunity against C. neoformans. We found that transient depletion of TNF-α inhibited pulmonary fungal clearance and enhanced extrapulmonary dissemination of C. neoformans during the adaptive phase of the immune response. Higher fungal burdens in TNF-α-depleted mice were accompanied by markedly impaired Th1 and Th17 responses in the infected lungs. Furthermore, early TNF-α depletion also resulted in disrupted transcriptional initiation of the Th17 polarization program and subsequent upregulation of Th1 genes in CD4+ T cells in the lung-associated lymph nodes (LALN) of C. neoformans-infected mice. These defects in LALN T cell responses were preceded by a dramatic shift from a classical toward an alternative activation of dendritic cells (DC) in the LALN of TNF-α-depleted mice. Taken together, our results indicate that early TNF-α signaling is required for optimal DC activation, and the initial Th17 response followed by Th1 transcriptional prepolarization of T cells in the LALN, which further drives the development of protective immunity against cryptococcal infection in the lungs. Thus, administration of anti-TNF-α may introduce a particularly greater risk for newly acquired fungal infections that require generation of protective Th1/Th17 responses for their containment and clearance. IMPORTANCE Increased susceptibility to invasive fungal infections in patients on anti-TNF-α therapies underlines the need for understanding the cellular effects of TNF-α signaling in promoting protective immunity to fungal pathogens. Here, we demonstrate that early TNF-α signaling is required for classical activation and accumulation of DC in LALN of C. neoformans-infected mice. Subsequent transcriptional initiation of Th17 followed by Th1 programming in LALN results in pulmonary accumulation of gamma interferon- and interleukin-17A-producing T cells and effective fungal clearance. All of these crucial steps are severely impaired in mice that undergo anti-TNF-α treatment, consistent with their inability to clear C. neoformans. This study identified critical interactions between cells of the innate immune system (DC), the emerging T cell responses, and cytokine networks with a central role for TNF-α which orchestrate the development of the immune protection against cryptococcal infection. This information will be important in aiding development and understanding the potential side effects of immunotherapies.Jintao XuAlison J. EastmanAdam FlaczykLori M. NealGuolei ZhaoJacob CarolanAntoni N. MalachowskiValerie R. StolbergMohammed YosriStephen W. ChensueJeffrey L. CurtisJohn J. OsterholzerMichal A. OlszewskiAmerican Society for MicrobiologyarticleMicrobiologyQR1-502ENmBio, Vol 7, Iss 4 (2016)
institution DOAJ
collection DOAJ
language EN
topic Microbiology
QR1-502
spellingShingle Microbiology
QR1-502
Jintao Xu
Alison J. Eastman
Adam Flaczyk
Lori M. Neal
Guolei Zhao
Jacob Carolan
Antoni N. Malachowski
Valerie R. Stolberg
Mohammed Yosri
Stephen W. Chensue
Jeffrey L. Curtis
John J. Osterholzer
Michal A. Olszewski
Disruption of Early Tumor Necrosis Factor Alpha Signaling Prevents Classical Activation of Dendritic Cells in Lung-Associated Lymph Nodes and Development of Protective Immunity against Cryptococcal Infection
description ABSTRACT Anti-tumor necrosis factor alpha (anti-TNF-α) therapies have been increasingly used to treat inflammatory diseases and are associated with increased risk of invasive fungal infections, including Cryptococcus neoformans infection. Using a mouse model of cryptococcal infection, we investigated the mechanism by which disruption of early TNF-α signaling results in the development of nonprotective immunity against C. neoformans. We found that transient depletion of TNF-α inhibited pulmonary fungal clearance and enhanced extrapulmonary dissemination of C. neoformans during the adaptive phase of the immune response. Higher fungal burdens in TNF-α-depleted mice were accompanied by markedly impaired Th1 and Th17 responses in the infected lungs. Furthermore, early TNF-α depletion also resulted in disrupted transcriptional initiation of the Th17 polarization program and subsequent upregulation of Th1 genes in CD4+ T cells in the lung-associated lymph nodes (LALN) of C. neoformans-infected mice. These defects in LALN T cell responses were preceded by a dramatic shift from a classical toward an alternative activation of dendritic cells (DC) in the LALN of TNF-α-depleted mice. Taken together, our results indicate that early TNF-α signaling is required for optimal DC activation, and the initial Th17 response followed by Th1 transcriptional prepolarization of T cells in the LALN, which further drives the development of protective immunity against cryptococcal infection in the lungs. Thus, administration of anti-TNF-α may introduce a particularly greater risk for newly acquired fungal infections that require generation of protective Th1/Th17 responses for their containment and clearance. IMPORTANCE Increased susceptibility to invasive fungal infections in patients on anti-TNF-α therapies underlines the need for understanding the cellular effects of TNF-α signaling in promoting protective immunity to fungal pathogens. Here, we demonstrate that early TNF-α signaling is required for classical activation and accumulation of DC in LALN of C. neoformans-infected mice. Subsequent transcriptional initiation of Th17 followed by Th1 programming in LALN results in pulmonary accumulation of gamma interferon- and interleukin-17A-producing T cells and effective fungal clearance. All of these crucial steps are severely impaired in mice that undergo anti-TNF-α treatment, consistent with their inability to clear C. neoformans. This study identified critical interactions between cells of the innate immune system (DC), the emerging T cell responses, and cytokine networks with a central role for TNF-α which orchestrate the development of the immune protection against cryptococcal infection. This information will be important in aiding development and understanding the potential side effects of immunotherapies.
format article
author Jintao Xu
Alison J. Eastman
Adam Flaczyk
Lori M. Neal
Guolei Zhao
Jacob Carolan
Antoni N. Malachowski
Valerie R. Stolberg
Mohammed Yosri
Stephen W. Chensue
Jeffrey L. Curtis
John J. Osterholzer
Michal A. Olszewski
author_facet Jintao Xu
Alison J. Eastman
Adam Flaczyk
Lori M. Neal
Guolei Zhao
Jacob Carolan
Antoni N. Malachowski
Valerie R. Stolberg
Mohammed Yosri
Stephen W. Chensue
Jeffrey L. Curtis
John J. Osterholzer
Michal A. Olszewski
author_sort Jintao Xu
title Disruption of Early Tumor Necrosis Factor Alpha Signaling Prevents Classical Activation of Dendritic Cells in Lung-Associated Lymph Nodes and Development of Protective Immunity against Cryptococcal Infection
title_short Disruption of Early Tumor Necrosis Factor Alpha Signaling Prevents Classical Activation of Dendritic Cells in Lung-Associated Lymph Nodes and Development of Protective Immunity against Cryptococcal Infection
title_full Disruption of Early Tumor Necrosis Factor Alpha Signaling Prevents Classical Activation of Dendritic Cells in Lung-Associated Lymph Nodes and Development of Protective Immunity against Cryptococcal Infection
title_fullStr Disruption of Early Tumor Necrosis Factor Alpha Signaling Prevents Classical Activation of Dendritic Cells in Lung-Associated Lymph Nodes and Development of Protective Immunity against Cryptococcal Infection
title_full_unstemmed Disruption of Early Tumor Necrosis Factor Alpha Signaling Prevents Classical Activation of Dendritic Cells in Lung-Associated Lymph Nodes and Development of Protective Immunity against Cryptococcal Infection
title_sort disruption of early tumor necrosis factor alpha signaling prevents classical activation of dendritic cells in lung-associated lymph nodes and development of protective immunity against cryptococcal infection
publisher American Society for Microbiology
publishDate 2016
url https://doaj.org/article/bc50d61b42f745fba1b55ad5c2d86803
work_keys_str_mv AT jintaoxu disruptionofearlytumornecrosisfactoralphasignalingpreventsclassicalactivationofdendriticcellsinlungassociatedlymphnodesanddevelopmentofprotectiveimmunityagainstcryptococcalinfection
AT alisonjeastman disruptionofearlytumornecrosisfactoralphasignalingpreventsclassicalactivationofdendriticcellsinlungassociatedlymphnodesanddevelopmentofprotectiveimmunityagainstcryptococcalinfection
AT adamflaczyk disruptionofearlytumornecrosisfactoralphasignalingpreventsclassicalactivationofdendriticcellsinlungassociatedlymphnodesanddevelopmentofprotectiveimmunityagainstcryptococcalinfection
AT lorimneal disruptionofearlytumornecrosisfactoralphasignalingpreventsclassicalactivationofdendriticcellsinlungassociatedlymphnodesanddevelopmentofprotectiveimmunityagainstcryptococcalinfection
AT guoleizhao disruptionofearlytumornecrosisfactoralphasignalingpreventsclassicalactivationofdendriticcellsinlungassociatedlymphnodesanddevelopmentofprotectiveimmunityagainstcryptococcalinfection
AT jacobcarolan disruptionofearlytumornecrosisfactoralphasignalingpreventsclassicalactivationofdendriticcellsinlungassociatedlymphnodesanddevelopmentofprotectiveimmunityagainstcryptococcalinfection
AT antoninmalachowski disruptionofearlytumornecrosisfactoralphasignalingpreventsclassicalactivationofdendriticcellsinlungassociatedlymphnodesanddevelopmentofprotectiveimmunityagainstcryptococcalinfection
AT valerierstolberg disruptionofearlytumornecrosisfactoralphasignalingpreventsclassicalactivationofdendriticcellsinlungassociatedlymphnodesanddevelopmentofprotectiveimmunityagainstcryptococcalinfection
AT mohammedyosri disruptionofearlytumornecrosisfactoralphasignalingpreventsclassicalactivationofdendriticcellsinlungassociatedlymphnodesanddevelopmentofprotectiveimmunityagainstcryptococcalinfection
AT stephenwchensue disruptionofearlytumornecrosisfactoralphasignalingpreventsclassicalactivationofdendriticcellsinlungassociatedlymphnodesanddevelopmentofprotectiveimmunityagainstcryptococcalinfection
AT jeffreylcurtis disruptionofearlytumornecrosisfactoralphasignalingpreventsclassicalactivationofdendriticcellsinlungassociatedlymphnodesanddevelopmentofprotectiveimmunityagainstcryptococcalinfection
AT johnjosterholzer disruptionofearlytumornecrosisfactoralphasignalingpreventsclassicalactivationofdendriticcellsinlungassociatedlymphnodesanddevelopmentofprotectiveimmunityagainstcryptococcalinfection
AT michalaolszewski disruptionofearlytumornecrosisfactoralphasignalingpreventsclassicalactivationofdendriticcellsinlungassociatedlymphnodesanddevelopmentofprotectiveimmunityagainstcryptococcalinfection
_version_ 1718427424221298688